Tocqueville Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.2M Sell
301,191
-1,623
-0.5% -$145K 0.41% 72
2026
Q1
$21.7M Sell
302,814
-6,333
-2% -$488K 0.32% 87
2025
Q4
$24.5M Buy
309,147
+1,986
+0.6% +$157K 0.36% 76
2025
Q3
$23.2M Sell
307,161
-76,936
-20% -$5.27M 0.34% 83
2025
Q2
$26.5M Buy
384,097
+379,087
+7,567% +$24.9M 0.4% 73
2025
Q1
$339K Sell
5,010
-894
-15% -$53.5K 0.01% 449
2024
Q4
$265K Sell
5,904
-6,591
-53% -$370K ﹤0.01% 495
2024
Q3
$786K Sell
12,495
-4,015
-24% -$234K 0.01% 368
2024
Q2
$975K Buy
16,510
+4,094
+33% +$256K 0.02% 335
2024
Q1
$990K Sell
12,416
-352
-3% -$26.9K 0.02% 343
2023
Q4
$1.01M Sell
12,768
-692
-5% -$49.3K 0.02% 336
2023
Q3
$940K Buy
13,460
+1,290
+11% +$91.4K 0.02% 340
2023
Q2
$841K Sell
12,170
-2,431
-17% -$173K 0.02% 366
2023
Q1
$1.08M Buy
14,601
+112
+0.8% +$9.39K 0.02% 335
2022
Q4
$1.35M Hold
14,489
0.03% 339
2022
Q3
$1.38M Buy
14,489
+459
+3% +$45.4K 0.03% 323
2022
Q2
$1.3M Sell
14,030
-850
-6% -$83K 0.02% 365
2022
Q1
$1.51M Sell
14,880
-1,410
-9% -$148K 0.02% 373
2021
Q4
$1.68M Sell
16,290
-1,080
-6% -$99.8K 0.02% 401
2021
Q3
$1.47M Sell
17,370
-864
-5% -$72.4K 0.02% 409
2021
Q2
$1.52M Sell
18,234
-1,708
-9% -$140K 0.02% 405
2021
Q1
$1.5M Buy
19,942
+3,305
+20% +$241K 0.02% 401
2020
Q4
$1.14M Buy
16,637
+1,010
+6% +$65.7K 0.02% 424
2020
Q3
$913K Sell
15,627
-1,612
-9% -$100K 0.02% 410
2020
Q2
$1.12M Buy
17,239
+225
+1% +$14.2K 0.02% 374
2020
Q1
$1.01M Buy
17,014
+240
+1% +$16K 0.03% 357
2019
Q4
$1.25M Sell
16,774
-841
-5% -$59.1K 0.02% 421
2019
Q3
$1.11M Buy
17,615
+1,383
+9% +$82K 0.02% 451
2019
Q2
$884K Buy
16,232
+12
+0.1% +$646 0.01% 503
2019
Q1
$875K Sell
16,220
-6,015
-27% -$371K 0.01% 494
2018
Q4
$1.46M Buy
22,235
+8,092
+57% +$604K 0.02% 417
2018
Q3
$1.11M Sell
14,143
-916
-6% -$65.5K 0.01% 488
2018
Q2
$969K Buy
15,059
+1,095
+8% +$72.2K 0.01% 514
2018
Q1
$869K Buy
13,964
+2,733
+24% +$196K 0.01% 523
2017
Q4
$814K Sell
11,231
-2,787
-20% -$203K 0.01% 541
2017
Q3
$1.14M Buy
14,018
+4,964
+55% +$393K 0.01% 513
2017
Q2
$728K Buy
9,054
+2,480
+38% +$196K 0.01% 540
2017
Q1
$516K Sell
6,574
-71,845
-92% -$5.74M 0.01% 585
2016
Q4
$6.19M Sell
78,419
-7,600
-9% -$615K 0.08% 252
2016
Q3
$7.66M Sell
86,019
-1,978
-2% -$187K 0.09% 229
2016
Q2
$8.43M Sell
87,997
-611
-0.7% -$60.9K 0.1% 214
2016
Q1
$9.19M Buy
88,608
+2,611
+3% +$254K 0.12% 191
2015
Q4
$8.41M Buy
85,997
+8,777
+11% +$860K 0.11% 201
2015
Q3
$7.45M Buy
77,220
+805
+1% +$84.6K 0.1% 235
2015
Q2
$8.01M Sell
76,415
-603
-0.8% -$61.6K 0.09% 234
2015
Q1
$7.95M Buy
77,018
+1,095
+1% +$111K 0.09% 240
2014
Q4
$7.31M Buy
75,923
+385
+0.5% +$33.9K 0.08% 253
2014
Q3
$6.01M Buy
75,538
+2,456
+3% +$194K 0.07% 266
2014
Q2
$5.51M Buy
73,082
+12,910
+21% +$976K 0.05% 296
2014
Q1
$4.5M Buy
60,172
+1,200
+2% +$84.8K 0.06% 268
2013
Q4
$4.22M Buy
58,972
+8,327
+16% +$535K 0.06% 282
2013
Q3
$2.87M Buy
50,645
+44,175
+683% +$2.63M 0.04% 378
2013
Q2
$370K Buy
+6,470
New +$375K 0.01% 713

Other funds holding CVS

Tocqueville Asset Management's CVS Position: Q2 2026 in Review

Tocqueville Asset Management reduced its CVS Health (CVS) stake by 0.54% in Q2 2026, selling an estimated $145K and leaving 301,191 shares worth $31.2M. The position accounts for 0.41% of the portfolio, ranked #72.

Tocqueville Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Tocqueville Asset Management held 301,191 shares of CVS Health worth $31.2M as of Q2 2026.
  • Tocqueville Asset Management sold 1,623 CVS Health shares in Q2 2026, an estimated $145K.
  • CVS Health made up 0.41% of Tocqueville Asset Management's portfolio in Q2 2026, its #72 holding.
  • Tocqueville Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.